http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009102814-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a2a26a7ccd46d0877bdb7f4ba7f1ff http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7e763fc2bd0a3ea2d5262b83dda4373 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6bc7541d36ce88659e1293e91601b539 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1611 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 |
| filingDate | 2009-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_340a34783ea30345ef3ee740cf94393a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3214fc626ec679389eb86005f7f7e65a |
| publicationDate | 2009-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2009102814-A2 |
| titleOfInvention | Mucosally non-irritative liquid amphotericin b formulations and methods for treating non-invasive fungus-induced mucositis |
| abstract | The present invention is directed to liquid compositions and methods for non-irritatively treating and preventing non-invasive fungus-induced mucositis. Specifically, the invention involves liquid compositions including a mucosally non-irritative mixture of amphotericin B and a pharmaceutically acceptable carrier. Such compositions can be non-irritatively mucoadministered to prevent, reduce, or eliminate chronic non-invasive fungus-induced mucositis conditions. In some embodiments, the compositions are stored in a sealed container under an inert gas atmosphere (e.g., nitrogen) prior to mucoadministration, which provide enhanced stability. Other aspects of the invention are sealed containers containing a liquid composition comprising a mucosally non-irritative mixture of amphotericin B; a pharmaceutically acceptable carrier; and an inert gas headspace, such as pure, medical grade nitrogen. |
| priorityDate | 2008-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 505.